These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 12072190)

  • 1. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
    Knutson KL; Disis ML
    Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.
    Knutson KL; Schiffman K; Cheever MA; Disis ML
    Clin Cancer Res; 2002 May; 8(5):1014-8. PubMed ID: 12006513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.
    Knutson KL; Schiffman K; Disis ML
    J Clin Invest; 2001 Feb; 107(4):477-84. PubMed ID: 11181647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.
    Zaks TZ; Rosenberg SA
    Cancer Res; 1998 Nov; 58(21):4902-8. PubMed ID: 9809997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern.
    Höhn H; Kortsik C; Nilges K; Necker A; Freitag K; Tully G; Neukirch C; Maeurer MJ
    Immunology; 2001 Nov; 104(3):278-88. PubMed ID: 11722642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.
    Sotiropoulou PA; Perez SA; Voelter V; Echner H; Missitzis I; Tsavaris NB; Papamichail M; Baxevanis CN
    Cancer Immunol Immunother; 2003 Dec; 52(12):771-9. PubMed ID: 13680193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
    Spits H; Paliard X; Engelhard VH; de Vries JE
    J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
    Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
    PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles.
    Li L; Yang B; Yu S; Zhang X; Lao S; Wu C
    PLoS One; 2013; 8(12):e82196. PubMed ID: 24349220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire.
    Liang X; Weigand LU; Schuster IG; Eppinger E; van der Griendt JC; Schub A; Leisegang M; Sommermeyer D; Anderl F; Han Y; Ellwart J; Moosmann A; Busch DH; Uckert W; Peschel C; Krackhardt AM
    J Immunol; 2010 Feb; 184(3):1617-29. PubMed ID: 20042572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class 1 expression.
    Kono K; Halapi E; Hising C; Petersson M; Gerdin E; Vanky F; Kiessling R
    Int J Cancer; 1997 Jan; 70(1):112-9. PubMed ID: 8985099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire.
    Lim A; Trautmann L; Peyrat MA; Couedel C; Davodeau F; Romagné F; Kourilsky P; Bonneville M
    J Immunol; 2000 Aug; 165(4):2001-11. PubMed ID: 10925283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer.
    Kono K; Takahashi A; Sugai H; Fujii H; Choudhury AR; Kiessling R; Matsumoto Y
    Clin Cancer Res; 2002 Nov; 8(11):3394-400. PubMed ID: 12429626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells.
    Henle AM; Erskine CL; Benson LM; Clynes R; Knutson KL
    J Immunol; 2013 Jan; 190(1):479-88. PubMed ID: 23180824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
    Karyampudi L; Formicola C; Erskine CL; Maurer MJ; Ingle JN; Krco CJ; Wettstein PJ; Kalli KR; Fikes JD; Beebe M; Hartmann LC; Disis ML; Ferrone S; Ishioka G; Knutson KL
    Clin Cancer Res; 2010 Feb; 16(3):825-34. PubMed ID: 20103660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.
    Voss RH; Kuball J; Engel R; Guillaume P; Romero P; Huber C; Theobald M
    Immunol Res; 2006; 34(1):67-87. PubMed ID: 16720899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
    Correale J; Rojany M; Weiner LP
    J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.